Dear Friends,
As we welcome the fall season, we are proud to share The Pink Agenda’s 2024 Annual Report, which highlights the extraordinary progress we’ve made together. To date, TPA has raised more than $11.5 million in support of breast cancer research and care—and this year, through our partnership with the Breast Cancer Research Foundation (BCRF), we are making our greatest impact yet with a $1.5 million contribution to fund the best and brightest breast cancer researchers in the field.
And now, as we step into Breast Cancer Awareness Month next week, our work takes on even greater urgency. We are thrilled to launch a powerful new campaign in Times Square (Northeast corner of West 43rd and Broadway)—reminding the world that $25 funds 30 minutes of breast cancer research. You have the power to change everything. Join us and fuel the future of life-changing research.
We hope you’ll take a moment to read our Annual Report and see the tangible difference your support is making. Together, we are creating more hope, more breakthroughs, and more moments of joy for all those impacted by breast cancer.
With gratitude and determination,
Nicole Seagriff
President, TPA
Serra Eken
Managing Director, TPA
Annual Pink on the River
On Sunday, September 7, The Pink Agenda hosted Pink on the River at RPM Events—and it was our most successful Chicago event yet! More than 550 guests came together in celebration and solidarity, raising over $475,000 (and counting!) benefitting The Pink Agenda and Giuliana Rancic’s FAB-U-WISH program.
The afternoon, hosted once again by Giuliana and Bill Rancic, featured an inspiring program where thrivers and survivors shared their personal stories underscoring why breast cancer research is essential. Guests also enjoyed incredible activations, along with a high-energy silent auction, raffles, and grab bags, all fueling a day of generosity and impact.
A heartfelt thank you to our Co-chairs, Chicago Committee, Host Committee, Sponsors, Event Partners, and incredible volunteers, whose passion and leadership made this event possible. Most importantly, thank you to our supporters—your commitment ensures that Chicago continues to thrive as a chapter city, and together, we are fueling the future of breast cancer research and making wishes come true through FAB-U-WISH.
We are so grateful to everyone who joined us and helped make this year’s Pink on the River truly unforgettable.
Annual New York Gala
The Pink Agenda’s Annual New York Gala returns to Tribeca Rooftop on Thursday, October 9, at 7:30 PM. This year, we look forward to coming together in celebration and solidarity as we raise critical funds and awareness for groundbreaking breast cancer research.
The evening will feature music by Ya Girl Ash, exciting activations, a silent auction with something for everyone, and a live auction led by NBC 4 NY’s Adam Kuperstein. Patron-level guests and sponsors will also enjoy our highly coveted gift bag.
We are proud to present The Pink Agenda Icon Award to Dr. Eleonora Teplinsky, a renowned breast and gynecologic oncologist, educator, and advocate. Dr. Teplinsky has dedicated her career to advancing cancer care and making science more accessible for patients and families. She has also been a steadfast partner to The Pink Agenda—running with Team TPA in both the 2023 TCS New York City Marathon and the 2025 United Airlines New York Half Marathon and joining us as a featured speaker at TPA Talks 2024.
The award will be presented by actress and breast cancer survivor Miranda McKeon, making this a moment of celebration not only for Dr. Teplinsky’s extraordinary dedication but also for the progress we are making together.
Join us at TPA’s Annual New York Gala as we honor Dr. Teplinsky and continue fueling the future of breast cancer research.
Get New York Gala Ready: Pre-Gala Shopping Event
Join The Pink Agenda and alice + olivia for an evening of shopping, style, and purpose on Monday, September 29, from 5:00 –7:00 PM at the Madison Avenue boutique. Guests will receive 10% off purchases, and alice + olivia will donate 10% of sales to support life-changing breast cancer research. The event is hosted by our New York Gala Co-Chairs and Vice-Chairs. Email: rsvp@thepinkagenda.org to attend.
Annual Atlanta Gala
The Pink Agenda’s Annual Atlanta Gala returns on Thursday, October 23, at 7:00 PM, at our new venue, The Dogwood. The evening will feature great food, music, and a fabulous silent auction—all in support of life-changing breast cancer research.
This year, we are proud to honor a deserving woman with a FAB-U-WISH, recognizing her courage and resilience while celebrating the transformative impact of The Pink Agenda’s programs.
Join us as we come together to raise funds, raise awareness, and make a lasting impact in the lives of those living with breast cancer.
TPA Supper Club
On Saturday, September 20, The Pink Agenda hosted TPA Supper Club: Brunch Edition at Quality Bistro in New York. Dr. Paul Baron, Chief of Breast Surgery at Lenox Hill Hospital, led an engaging discussion on the future of breast cancer research, lifestyle strategies to reduce risk, and genetics, with added insights from Dr. Lisa Baron, Chief of the Division of Breast Imaging at Lenox Hill Hospital.
Be part of the conversation at our upcoming TPA Supper Club events in Palm Beach, Los Angeles, and New York.
TPA Supper Club Palm Beach
Tuesday, October 21
kitchen, 319 Belvedere Road
TPA Supper Club Los Angeles
Thursday, November 6
3278 Wilshire Boulevard, 8th Floor
TPA Supper Club New York
Tuesday, November 18
MM Kitchen, 179 W Broadway
Each gathering brings together young professionals who share a love of good food and meaningful conversation. Every dinner explores a different theme and features a range of experts—sharing both research insights and personal experiences—to spark thoughtful dialogue about the many ways breast cancer affects our community.
Research Updates
Dr. Susan Domchek is exploring how BRCA1 and BRCA2 gene mutations, linked to increased risks of several cancers, affect immune system responses. Her team is investigating how these mutations in tumors lead to DNA damage and influence immune cell activity, with the goal of developing personalized prevention strategies like immunotherapies and vaccines, improving early detection, and refining future screening and treatment approaches.
Dr. Dawn Hershman is working to improve breast cancer care by focusing on treatment adherence, quality of life, and the long-term effects of therapy for patients with advanced and metastatic breast cancer. Her team is studying factors that affect therapy adherence, including financial and social challenges, and is developing risk prediction models to identify patients who may need additional support. They are also investigating ovarian function suppression and strategies to reduce unplanned hospitalizations, with the goal of refining interventions and informing future treatment guidelines.
Dr. Neil Iyengar is developing personalized lifestyle interventions to improve health outcomes and quality of life for people with breast cancer. His team is studying diet, exercise, and metabolic health beginning at the time of diagnosis, aiming to reduce cancer recurrence and support survivorship. The Healthy Living Program provides individualized plans and digital tools to help patients transition from treatment to recovery, improve energy and wellbeing, and adopt sustainable, cancer-protective behaviors.
Dr. Yibin Kang is investigating why immunotherapy has been less effective in breast cancer, particularly metastatic disease. His team is studying how the protein MTDH suppresses the immune system and alters metabolism in distant organs like the liver. By targeting MTDH, they aim to boost cancer-fighting immune cells and develop strategies to enhance immunotherapy, offering new hope for patients with advanced breast cancer.
Dr. Ann Partridge focuses on improving care for young women with breast cancer, who face unique challenges. Her Young Women’s Breast Cancer Study (YWS) continues to uncover distinct genomic features and therapeutic targets, while the Young, Empowered and Strong (YES) Study provides virtual support to these patients. This year, Dr. Partridge is completing the YES studies, expanding access to care for younger women, and analyzing new data to refine personalized therapies and better understand breast cancer biology in this population.
Leadership
Are you dedicated to raising money for breast cancer research and care, and looking to get involved in a leadership capacity?
To learn more about serving on The Pink Agenda’s Board of Directors or Leadership Council, the application process, and to schedule an informational conversation, please click here or email nominating@thepinkagenda.org.